Analysis-Unilever and McCormick investors find $65 billion food deal hard to swallow

A proposed $65 billion tie-up between Unilever and McCormick knocked Unilever shares ~7% (≈$7bn market value) and McCormick ~5% as investors balked at the Reverse Morris Trust structure and the long timeline to close (not expected until mid-2027). The deal would leave Unilever shareholders with a large ownership stake (~65% stated; analysts cite alternative split figures), creating an ownership overhang and likely FTC scrutiny (30‑day review/second‑request risk), while sector headwinds — GLP‑1 driven shifts away from packaged food and Iran-related freight/energy cost pressures — add near‑term risk to execution.

Analysis

The market reaction understates a multi-year governance and liquidity issue: a large retained stake inside a tax-driven structure will act as a persistent float-and-vote overhang, compressing multiple expansion even if underlying margins normalise. That overhang amplifies volatility around every regulatory milestone and earnings print, making the parent’s beta structurally higher for the next 12–36 months and raising cost-of-capital for any integration capex.

Antitrust pressure is the clearest convex catalyst — not because of a binary block but because of likely remedial divestitures that fragment scale benefits. Those carve-outs create a bidding pipeline for midsize strategics and private equity, selectively re-rating acquirers (spice/condiment specialists, regional food groups) while leaving the combined firm with stripped categories and impaired synergies for at least 18 months.

Operationally, near-term margin compression is more likely to come from logistics/energy inflation and mix shifts driven by persistent weight-loss drug adoption and private label penetration than from successful SKU rationalisation. That implies a window where branded price elasticity will be tested and retailers will demand concessions, pressuring EBITDA ahead of any structural cost saves from consolidation.

Key Decisions for Investors

• Short UL (ticker: UL) 6–12 month equity or buy put spreads: sized 1–2% NAV using a 6–12 month 15–25% OTM put spread to limit tail risk. Rationale: overhang + higher beta into regulatory/events; target 20–35% downside if divestiture/slow integration headlines persist. Hedge: buy UL 18–24 month calls (~10% notional) to cap loss if deal passes cleanly.
• Pair trade — long MKC (MKC) vs short UL (UL) 1:1 for 6–18 months: MKC is the cleaner operating stub with narrower category overlap and faster cash conversion; expect relative outperformance if divestitures or integration snags hit UL. Size 1% NAV long MKC financed by 1% NAV short UL; stop-loss 12% adverse move.
• Event-driven long MKC options: buy MKC Jan-2028 LEAPS calls (or call spread) sized 0.5–1% NAV to capture upside from deal failure, favourable carve-up, or successful synergy messaging. Upside scenario >3x, max loss = premium.
• Prepare acquisition-arbitrage watchlist: K (Kellogg) and regional food companies — allocate dry powder (~1–2% NAV) to opportunistic buys if FTC requires carve-outs; these acquirers historically trade up 15–35% on bolt-on scale wins within 12 months.